Literature DB >> 7561957

Influence of peripheral nerve grafts on the expression of GAP-43 in regenerating retinal ganglion cells in adult hamsters.

T F Ng1, K F So, S K Chung.   

Abstract

We have examined the ability of axotomized retinal ganglion cells in adult hamsters, to regenerate axons into a peripheral nerve graft attached to the optic nerve and the expression of GAP-43 by these neurons. We also examined the effect on these events of transplanting a segment of peripheral nerve to the vitreous body. The left optic nerves in three groups of hamsters were replaced with a long segment of peripheral nerve attached to the proximal stump of the optic nerve approximately 2 mm from the optic disc to induce regeneration of retinal ganglion cells into the peripheral nerve. An additional segment of peripheral nerve was transplanted into the vitreous of the left eye in the second group. The animals from the first and second groups were allowed to survive for 1-8 weeks and the number of regenerating retinal ganglion cells was determined by applying the retrograde tracer, Fluoro-Gold to the peripheral nerve graft and the expression of GAP-43 was studied by immunocytochemistry in the same retinas. As a control, a segment of optic nerve was transplanted into the vitreous body of the left eye in the third group of hamsters. These animals were allowed to survive for 4 weeks and the number of regenerating retinal ganglion cells was counted as in Groups 1 and 2. The percentages of the regenerating retinal ganglion cells which also expressed GAP-43 were very high at all time points in Group 1 (with no intravitreal peripheral nerve) and Group 2 (with intravitreal peripheral nerve) and at 4 weeks for the Group 3 (with intravitreal optic nerve) animals. In addition, the number of regenerating retinal ganglion cells, the number of retinal ganglion cells expressing GAP-43 and the number of regenerating retinal ganglion cells which also expressed GAP-43 were much higher in Group 2 than in Group 1 at all the time points and it was also much higher in Group 2 than in Group 3 at 4 weeks whereas there was no significant difference between the results from Groups 1 and 3 at 4 weeks. These data suggested that there was a close correlation between the number of the axotomized retinal ganglion cells regenerating axons into the peripheral nerve graft attached to the optic nerve and the expression of GAP-43.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561957     DOI: 10.1007/BF01179974

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  6 in total

1.  Topological specificity in reinnervation of the superior colliculus by regenerated retinal ganglion cell axons in adult hamsters.

Authors:  Y Sauvé; H Sawai; M Rasminsky
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

Review 2.  Rewiring the injured CNS: lessons from the optic nerve.

Authors:  Larry Benowitz; Yuqin Yin
Journal:  Exp Neurol       Date:  2007-06-07       Impact factor: 5.330

3.  The influence of predegenerated nerve grafts on axonal regeneration from prelesioned peripheral nerves.

Authors:  N A Hasan; M M Neumann; M A de Souky; K F So; K S Bedi
Journal:  J Anat       Date:  1996-10       Impact factor: 2.610

4.  Up-regulation of GAP-43 in the chinchilla ventral cochlear nucleus after carboplatin-induced hearing loss: correlations with inner hair cell loss and outer hair cell loss.

Authors:  K S Kraus; D Ding; H Jiang; M H Kermany; S Mitra; R J Salvi
Journal:  Hear Res       Date:  2013-05-23       Impact factor: 3.208

5.  Lentiviral-mediated growth-associated protein-43 modification of bone marrow mesenchymal stem cells improves traumatic optic neuropathy in rats.

Authors:  Qi Zhu; Zaoxia Liu; Chenguang Wang; Lili Nie; Yuxi He; Yan Zhang; Xin Liu; Guanfang Su
Journal:  Mol Med Rep       Date:  2015-07-28       Impact factor: 2.952

6.  Optic Nerve Regeneration After Crush Remodels the Injury Site: Molecular Insights From Imaging Mass Spectrometry.

Authors:  David T Stark; David M G Anderson; Jacky M K Kwong; Nathan Heath Patterson; Kevin L Schey; Richard M Caprioli; Joseph Caprioli
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.